Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice

Successful Treatment of Animal Models of Rheumatoid Arthritis with Small-Molecule Cyclin-Dependent Kinase Inhibitors

(2014) C. Sekine et al.   JOURNAL OF IMMUNOLOGY

A randomized, pilot trial of etanercept in dermatomyositis

(2011)   ANNALS OF NEUROLOGY

Definitive engagement of cytotoxic CD8 T cells in C protein-induced myositis, a murine model of polymyositis

(2010) Takahiko Sugihara et al.   ARTHRITIS AND RHEUMATISM

Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature

(2010) Yuki Ishikawa et al.   CLINICAL RHEUMATOLOGY

Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A

(2009) Naoko Okiyama et al.   ARTHRITIS AND RHEUMATISM

Induction of Systemic Lupus Erythematosus with Tumor Necrosis Factor Blockers

(2009) E. SOFORO et al.   JOURNAL OF RHEUMATOLOGY

Interleukin-17 and Type 17 Helper T Cells

(2009) Pierre Miossec et al.   NEW ENGLAND JOURNAL OF MEDICINE

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies

(2008) M Dastmalchi et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

(2008) Josef S Smolen et al.   LANCET